{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:16Z","timestamp":1787003596191,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is no specific treatment for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome (PA-HSOS). It is not clear when transjugular intrahepatic portosystemic shunt (TIPS) should be implemented in PA-HSOS patients. This study aimed to evaluate the timing of TIPS using total bilirubin (TBIL) as a measure, and to investigate efficacy of TIPS. We retrospectively analyzed the medical records of 10 PA-HSOS patients, among whom 4 patients had received TIPS (TIPS group), and the remaining patients were assigned to the internal medicine group. In the TIPS group, the TBIL level before TIPS was 84.4\u2009\u00b1\u200945.2\u00a0\u00b5mol\/L (&gt;\u20093\u00a0mg\/dL), and TBIL levels were increased to different degrees after TIPS. With the extension of time, serum TBIL levels gradually decreased, and no liver failure occurred. With regards to the short-term outcomes, 3 patients recovered, 1 developed chronic illness and 0 died in the TIPS group. Moreover, 0 patients recovered, 5 developed chronic illness and 1 died in the internal medicine group. The rank sum test of group design revealed significant differences in clinical outcomes (P\u2009=\u20090.02). It was suggested that when the internal medicine effect of PA-HSOS patients is poor, TIPS should be considered, which is no trestricted to the limit of 3\u00a0mg\/dL TBIL. It was also found TIPS effectively promote the recovery of liver function and reduce the occurrence of chronicity.<\/jats:p>","DOI":"10.1038\/s41598-021-01201-w","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T07:06:21Z","timestamp":1636095981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","volume":"23","author":"A Helmy","year":"2006","unstructured":"Helmy, A. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharmacol Ther. 23, 11\u201325 (2006).","journal-title":"Aliment Pharmacol Ther."},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/S0168-8278(12)60004-X","volume":"56","author":"A Plessier","year":"2012","unstructured":"Plessier, A., Rautou, P. E. & Valla, D. C. Management of hepatic vascular diseases. J. Hepatol. 56, S25-38 (2012).","journal-title":"J. Hepatol."},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty, M. et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: Current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 50, 781\u2013789 (2015).","journal-title":"Bone Marrow Transplant."},{"key":"1201_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jgh.14612","volume":"34","author":"Y Zhuge","year":"2019","unstructured":"Zhuge, Y. et al. Chinese Society of Gastroenterology Committee of Hepatobiliary Disease. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. J. Gastroenterol. Hepatol. 34, 634\u2013642 (2019).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jep.2019.01.006","volume":"233","author":"JH Byeon","year":"2019","unstructured":"Byeon, J. H., Kil, J. H., Ahn, Y. C. & Son, C. G. Systematic review of published data on herb induced liver injury. J. Ethnopharmacol. 233, 190\u2013196 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"1201_CR6","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","volume":"25","author":"XQ Yang","year":"2019","unstructured":"Yang, X. Q., Ye, J., Li, X., Li, Q. & Song, Y. H. Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes. World J. Gastroenterol. 25, 3753\u20133763 (2019).","journal-title":"World J. Gastroenterol."},{"key":"1201_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3748\/wjg.v26.i7.706","volume":"26","author":"J Shin","year":"2020","unstructured":"Shin, J. et al. Liver stiffness and perfusion changes for hepatic sinusoidal obstruction syndrome in rabbit model. World J. Gastroenterol. 26, 706\u2013716 (2020).","journal-title":"World J. Gastroenterol."},{"key":"1201_CR8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve, L. D., Valla, D. C. & Garcia-Tsao, G. American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 49, 1729\u20131764 (2009).","journal-title":"Hepatology"},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.2174\/1381612825666191007162024","volume":"25","author":"P Ou","year":"2019","unstructured":"Ou, P. et al. Gynura segetum related hepatic sinusoidal obstruction syndrome: A liver disease with high mortality and misdiagnosis rate. Curr. Pharm. Des. 25, 3762\u20133768 (2019).","journal-title":"Curr. Pharm. Des."},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"10868","DOI":"10.1038\/s41598-017-11455-y","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Techniques and long-term effects of transjugular intrahepatic portosystemicshunt on liver cirrhosis-related thrombotic total occlusion of main portal vein. Sci. Rep. 7, 10868 (2017).","journal-title":"Sci. Rep."},{"key":"1201_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"FR De","year":"2015","unstructured":"De, F. R. & Faculty, B. V. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743\u2013752 (2015).","journal-title":"J. Hepatol."},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","volume":"69","author":"D Tripathi","year":"2020","unstructured":"Tripathi, D. et al. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 69, 1173\u20131192 (2020).","journal-title":"Gut"},{"key":"1201_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J. Hepatol. 69, 406\u2013460 (2018).","journal-title":"J. Hepatol."},{"key":"1201_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3348\/kjr.2014.15.2.218","volume":"15","author":"H Zhou","year":"2014","unstructured":"Zhou, H., Wang, Y. X., Lou, H. Y., Xu, X. J. & Zhang, M. M. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features. Korean J Radiol. 15, 218\u2013225 (2014).","journal-title":"Korean J Radiol."},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/MEG.0000000000001630","volume":"32","author":"C Peng","year":"2020","unstructured":"Peng, C. et al. Clinical efficacy and safety of anticoagulation therapy for Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: A retrospective multicenter cohort study. Eur. J. Gastroenterol. Hepatol. 32, 1168\u20131178 (2020).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","volume":"43","author":"M Senzolo","year":"2011","unstructured":"Senzolo, M., Riggio, O. & Primignani, M. Vascular disorders of the liver: Recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. Dig. Liver Dis. 43, 503\u2013514 (2011).","journal-title":"Dig. Liver Dis."},{"key":"1201_CR17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1111\/liv.13684","volume":"38","author":"YZ Zhuge","year":"2018","unstructured":"Zhuge, Y. Z. et al. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int. 38, 1867\u20131874 (2018).","journal-title":"Liver Int."},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12876-018-0879-7","volume":"18","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Qiao, D., Li, Y. & Xu, F. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: A retrospective study. BMC Gastroenterol. 18, 156 (2018).","journal-title":"BMC Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01201-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:09:17Z","timestamp":1670069357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-01201-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-01201-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21743"}}